Article Information
- Received December 14, 2004
- Revision received April 19, 2005
- Accepted April 21, 2005
- First published May 25, 2005.
- Version of record published May 25, 2005.
Author Information
- Gregorio Valdez1,
- Wendy Akmentin1,
- Polyxeni Philippidou1,
- Rejji Kuruvilla2,
- David D. Ginty2, and
- Simon Halegoua1
- 1Department of Neurobiology and Behavior, Center for Brain and Spinal Cord Research, State University of New York at Stony Brook, Stony Brook, New York 11794-5230, and 2Department of Neuroscience, Howard Hughes Medical Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205
Author contributions
Disclosures
- Received December 14, 2004.
- Revision received April 19, 2005.
- Accepted April 21, 2005.
This work was supported by National Institutes of Health Grant NS18218 (S.H.) and by the Howard Hughes Medical Institute (D.D.G.). We thank P. Brehm and G. Mandel for helpful discussions, N. Mendell for the statistical analyses, J. Rosenbaum for valuable technical assistance, M. Goldfarb for providing the EGFR/TrkB construct, D. Kaplan for the anti-TrkBin antibody, M. Chao for the TrkA construct, and R. Segal for the TrkB-GFP adenovirus.
Correspondence should be addressed to Simon Halegoua, Department of Neurobiology and Behavior, Center for Brain and Spinal Cord Research, State University of New York at Stony Brook, Stony Brook, NY 11794-5230. E-mail: simon.halegoua{at}sunysb.edu.
Copyright © 2005 Society for Neuroscience 0270-6474/05/255236-12$15.00/0
Online Impact